Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Deloitte
Chubb
Julphar
McKinsey
Chinese Patent Office
Moodys
Merck
AstraZeneca

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022501

« Back to Dashboard

NDA 022501 describes LO LOESTRIN FE, which is a drug marketed by Apil and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the LO LOESTRIN FE profile page.

The generic ingredient in LO LOESTRIN FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 022501
Tradename:LO LOESTRIN FE
Applicant:Apil
Ingredient:ethinyl estradiol; norethindrone acetate
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022501
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LO LOESTRIN FE ethinyl estradiol; norethindrone acetate TABLET;ORAL 022501 NDA Allergan, Inc. 0430-0420 N 0430-0420-14
LO LOESTRIN FE ethinyl estradiol; norethindrone acetate TABLET;ORAL 022501 NDA Allergan, Inc. 0430-0420 N 0430-0420-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.01MG,0.01MG;1MG,N/A
Approval Date:Oct 21, 2010TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Feb 2, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Medtronic
McKinsey
Citi
Cantor Fitzgerald
AstraZeneca
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.